Effect of doxycycline versus placebo on clinical outcomes in patients with ischemic stroke
Phase 3
Recruiting
- Conditions
- Ischemic stroke.Cerebral infarction
- Registration Number
- IRCT20120215009014N432
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Age 18 to 85 years
Ischemic stroke in the last 24 hours
Exclusion Criteria
Pregnancy or lactation
History of ischemic stroke
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eurological dysfunction. Timepoint: Before intervention, one week, one and three months later. Method of measurement: Using the NIH Stroke Scale (NIHSS).;Functional dysfunction. Timepoint: Before intervention, one week, one and three months later. Method of measurement: Using the modified Rankin Scale (mRS).
- Secondary Outcome Measures
Name Time Method